Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas

Autor: Sherrie L. Perkins, AS Masih, Carl R. Kjeldsberg, RC Braylan, Carl T. Wittwer, TC Meeker, RJ Molot, Glenn H. Segal

Publikováno v: Blood. 83:1626-1631

Flow immunophenotyping, DNA content analysis, and polymerase chain reaction (PCR) amplification for t(11;14) and t(14;18) were performed on 11 cases of typical mantle cell lymphoma (MCL), 5 cases of apparent MCL with proliferation centers (MCL-PC), a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1afe9e1835f93f81edffffbb27911893
https://doi.org/10.1182/blood.v83.6.1626.1626

Evolution of a lymphoma with helper T cell characteristics in Sezary syndrome

Autor: EC Lawrence, S Broder, WO Dobbins, ES Jaffe, RC Young, TA Waldmann, RC Braylan

Publikováno v: Blood. 52:481-492

A patient with Sezary syndrome presented with disease limited to the skin and circulating abnormal lymphocytes but subsequently developed a diffuse undifferentiated lymphoma. Malignant cells from a lymph node effaced with the morphologically undiffer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df95e2211ac5e51f31f9ab57a32ef5f
https://doi.org/10.1182/blood.v52.3.481.bloodjournal523481

Venous and arterial thrombosis in patients with VEXAS syndrome.

Autor: Kusne Y; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ., Ghorbanzadeh A; Division of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Dulau-Florea A; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Shalhoub R; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Alcedo PE; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Nghiem K; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Ferrada MA; Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD., Hines A; Department of Dermatology, Mayo Clinic, Rochester, MN., Quinn KA; Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD., Panicker SR; Laboratory of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Ombrello AK; Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD., Reichard K; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Darden I; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Goodspeed W; Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD., Durrani J; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Wilson L; Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD., Olteanu H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Lasho T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Kastner DL; Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD., Warrington KJ; Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Mangaonkar A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Go RS; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Braylan RC; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Beck DB; Laboratory of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Center for Human Genetics and Genomics, New York University School of Medicine, New York, NY., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Young NS; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Calvo KR; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Casanegra AI; Division of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Grayson PC; Vasculitis Translational Research Program, National Institute of Arthritis and Musculoskeletal, and Skin Diseases, National Institutes of Health, Bethesda, MD., Koster MJ; Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Wu CO; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Kanthi Y; Laboratory of Vascular Thrombosis and Inflammation, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Patel BA; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Houghton DE; Division of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Groarke EM; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Publikováno v: Blood [Blood] 2024 May 23; Vol. 143 (21), pp. 2190-2200.

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.

Autor: Chihara D; Medical Oncology Service., Arons E; Laboratory of Molecular Biology., Stetler-Stevenson M; Laboratory of Pathology., Yuan C; Laboratory of Pathology., Wang HW; Laboratory of Pathology., Zhou H; Laboratory of Molecular Biology., Raffeld M; Laboratory of Pathology., Xi L; Laboratory of Pathology., Steinberg SM; Biostatistics and Data Management Section, and., Feurtado J; Office of Research Nursing, National Cancer Institute, National Institutes of Health, Bethesda, MD., James-Echenique L; Laboratory of Molecular Biology., Tai CH; Laboratory of Molecular Biology., Patel KP; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX; and., Braylan RC; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Calvo KR; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Maric I; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Dulau-Florea A; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Kreitman RJ; Medical Oncology Service.; Laboratory of Molecular Biology.

Publikováno v: Blood advances [Blood Adv] 2021 Dec 14; Vol. 5 (23), pp. 4807-4816.

Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates ^☆ .

Autor: Dulau-Florea A; Department of Laboratory Medicine, Hematology Section, National Institutes of Health Clinical Center, Bethesda, MD. Electronic address: alina.dulau-florea@nih.gov., Maric I; Department of Laboratory Medicine, Hematology Section, National Institutes of Health Clinical Center, Bethesda, MD., Calvo KR; Department of Laboratory Medicine, Hematology Section, National Institutes of Health Clinical Center, Bethesda, MD., Braylan RC; Department of Laboratory Medicine, Hematology Section, National Institutes of Health Clinical Center, Bethesda, MD.

Publikováno v: Seminars in hematology [Semin Hematol] 2019 Jan; Vol. 56 (1), pp. 65-68. Date of Electronic Publication: 2018 May 27.